The US pulled in 9.6% of those projects but the Americas as a whole lagged behind Europe, which attracted more than 39% of projects, and Asia, with more than 23%. China attract 8.1% of projects. Although UK company GlaxoSmithKline led on projects undertaken and investment, US firms dominated in terms of number of projects (111), amount invested ($5881.9m) and number of jobs created (5613). The biggest investment was US company Amgen’s $800m plant in Puerto Rico to manufacture cardiovascular drugs to boost red and white blood cell production. Ireland attracted $300m from US firm Eli Lilly for an antibody production facility.
PHRMACEUTICALS: TOP 10 LOCATIONS BY NUMBER OF PROJECTS, JAN 2002- FEB 2005